Cost-Utility Analysis of Bariatric Surgery in Italy: Results of Decision-Analytic Modelling

被引:19
|
作者
Lucchese, Marcello [1 ]
Borisenko, Oleg [2 ]
Mantovani, Lorenzo Giovanni [3 ]
Cortesi, Paolo Angelo [3 ]
Cesana, Giancarlo C. [3 ]
Adam, Daniel [2 ]
Burdukova, Elisabeth [2 ]
Lukyanov, Vasily [2 ]
Di Lorenzo, Nicola [4 ]
机构
[1] Santa Maria Nuova Hosp, Bariatr Gen Surg & Metab Dept, Florence, Italy
[2] Synergus AB, Danderyd, Sweden
[3] Univ Milano Bicocca, Res Ctr Publ Hlth CESP, Milan, Italy
[4] Univ Tor Vergata, Appl Expt Med & Surg Dept, Rome, Italy
关键词
Bariatric surgery; Cost-Benefit analysis; Italy; Y GASTRIC BYPASS; PROSPECTIVE RANDOMIZED-TRIAL; BODY-MASS INDEX; QUALITY-OF-LIFE; HEART-FAILURE; WEIGHT-LOSS; MYOCARDIAL-INFARCTION; BLOOD-PRESSURE; RISK-FACTORS; OBESITY;
D O I
10.1159/000475842
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To evaluate the cost-effectiveness of bariatric surgery in Italy from a third-party payer perspective over a medium-term (10 years) and a long-term (lifetime) horizon. Methods: A state-transition Markov model was developed, in which patients may experience surgery, post-surgery complications, diabetes mellitus type 2, cardiovascular diseases or die. Transition probabilities, costs, and utilities were obtained from the Italian and international literature. Three types of surgeries were considered: gastric bypass, sleeve gastrectomy, and adjustable gastric banding. A base-case analysis was performed for the population, the characteristics of which were obtained from surgery candidates in Italy. Results: In the base-case analysis, over 10 years, bariatric surgery led to cost increment of EUR 2,661 and generated additional 1.1 quality-adjusted life years (QALYs). Over a lifetime, surgery led to savings of EUR 8,649, additional 0.5 life years and 3.2 QALYs. Bariatric surgery was cost-effective at 10 years with an incremental cost-effectiveness ratio of EUR 2,412/QALY and dominant over conservative management over a lifetime. Conclusion: In a comprehensive decision analytic model, a current mix of surgical methods for bariatric surgery was cost-effective at 10 years and costsaving over the lifetime of the Italian patient cohort considered in this analysis. (C) 2017 The Author(s) Published by S. Karger GmbH, Freiburg
引用
收藏
页码:261 / 272
页数:12
相关论文
共 50 条
  • [21] Cost-utility analysis for endoscopic sinus surgery
    Wang, PC
    Chu, CC
    Liang, SC
    Tai, CJ
    [J]. OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2004, 130 (01) : 31 - 38
  • [22] The Cost, Quality of Life Impact, and Cost-Utility of Bariatric Surgery in a Managed Care Population
    McEwen, Laura N.
    Coelho, Renuka B.
    Baumann, Lauren M.
    Bilik, Dori
    Nota-Kirby, Betsy
    Herman, William H.
    [J]. OBESITY SURGERY, 2010, 20 (07) : 919 - 928
  • [23] SCALABLE DECISION-ANALYTIC MODELLING WITH INFLUENCE DIAGRAMS
    Gupta, A.
    Brenner, D. R.
    Arora, P.
    [J]. VALUE IN HEALTH, 2019, 22 : S251 - S251
  • [24] Combining a Budgetary-Impact Analysis and a Cost-Effectiveness Analysis Using Decision-Analytic Modelling Techniques
    Mark J.C. Nuijten
    Frans Rutten
    [J]. PharmacoEconomics, 2002, 20 : 855 - 867
  • [25] Combining a budgetary-impact analysis and a cost-effectiveness analysis using decision-analytic modelling techniques
    Nuijten, MJC
    Rutten, F
    [J]. PHARMACOECONOMICS, 2002, 20 (12) : 855 - 867
  • [26] Cost-utility analysis of antihypertensive medications in Nigeria: A decision analysis
    Ekwunife O.I.
    Okafor C.E.
    Ezenduka C.C.
    Udeogaranya P.O.
    [J]. Cost Effectiveness and Resource Allocation, 11 (1)
  • [27] Cost-Utility Analysis of Antihypertensive Medications in Nigeria: A Decision Analysis
    Ekwunife, Obinna I.
    Okafor, Charles E.
    Ezenduka, Charles C.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 316 - 316
  • [28] Cost-Utility Analysis of Antihypertensive Medications in Morocco: A Decision Analysis
    El Azizi, Ghizlane Berrada
    Ahid, Samir
    Abir-Khalil, Saadia
    Ellouali, Fedoua
    El Majhad, Amine
    D'Ouazzane, Mouna Charif
    Mouram, Sahar
    Boukili, Abdeali
    Cherti, Mohammed
    Hassar, Mohammed
    Cherrah, Yahia
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2013, 22 : 431 - 431
  • [29] A DECISION ANALYTIC MARKOV MODEL TO COMPARE THE COST-UTILITY OF TVT VERSUS DULOXETINE
    Renganathan, A.
    Duckett, J. R.
    [J]. INTERNATIONAL UROGYNECOLOGY JOURNAL, 2009, 20 : S217 - S218
  • [30] Cost-utility analysis
    Brown, GC
    Brown, MM
    Sharma, S
    [J]. ANNALS OF INTERNAL MEDICINE, 2001, 134 (07) : 625 - 626